Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

US Patent 6852712 · Granted Feb 8, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PD-1 antibodies and uses thereof2025
Apolipoprotein nanodiscs with telodendrimer2025
Aminopyrimidine derivatives as cyclin-dependent kinase inhibitors2025
Compounds having BET, estrogen receptor, and androgen receptor degradation activ2025
Combination cancer immunotherapies with arginine depletion agents2025
Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereof2025
Essential oil composition and preparation method thereof2024
Glutarimide-containing KRAS-mutant degrader compounds and uses thereof2024
Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereof2024
Nanolipoprotein particles and related compositions methods and systems for loadi2024
Caspase inhibitors and methods of use thereof2024
Method for preparing isophorone diisocyanate2024